Thermo Fisher Scientific (TMO) stock
NYSE
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $259.8B
- As of Nov 13, 2026
- P/E
- 36.73x
- Trailing twelve months
- P/B
- 4.74x
- Latest reported equity
- P/S
- 5.49x
- Trailing twelve months
- ROE
- 12.9%
- Trailing twelve months
- Dividend yield
- 0.25%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $259.8B
- As of Nov 13, 2026
- P/E
- 36.73x
- Trailing twelve months
- P/B
- 4.74x
- Latest reported equity
- P/S
- 5.49x
- Trailing twelve months
- ROE
- 12.9%
- Trailing twelve months
- Dividend yield
- 0.25%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
36.73x
P/B
4.74x
P/S
5.49x
Earnings and dividend metrics▾
Earnings
EPS
$19.06
Earnings per share
BPS
$147.60
Book value per share
ROE
12.9%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $19.06 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $147.60 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 12.9%.
Dividends
Yield
0.25%
Dividend per share
$1.72
Payout ratio
9.0%
Consecutive years
14+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $172.00 before tax.
- Payout ratio — 9.0% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 14 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 9.1% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $11.1B+9.1%
$10.6B
Jul–Sep '24
$11.1B
Jul–Sep '25
$12.1B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 30, 2026.
- Earnings per share increased 8.7% from the same quarter a year earlier.
- Revenue increased 9.1% from the same quarter a year earlier.
- Operating income increased 16.6% from the same quarter a year earlier.
- Net income increased 6.5% from the same quarter a year earlier.
Filed Oct 30, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Britt Lisa P.Sr. VP and Chief HR Officer · Oct 28, 2026Open-market sale2,831 shares · $2.0MAvg. price $706.4511,560 shares held after
- SPERLING SCOTT MDirector · Oct 28, 2026Gift3,490 shares · $0Avg. price $065,989 shares held after
- Pettiti GianlucaPresident & COO · Aug 31, 2026Open-market sale4,133 shares · $2.5MAvg. price $614.3823,216 shares held after
Show 2 price lots
- 3,733 shares × $614.38$2.3M
- 400 shares × $614.38$246K
- Pettiti GianlucaPresident & COO · Aug 31, 2026Option exercise3,733 shares · $1.2MAvg. price $309.6326,949 shares held after
- CASPER MARC NChairman & CEO · Aug 28, 2026Shares withheld for taxes1,257 shares · $782KAvg. price $622.18
Show 2 price lots
- 725 shares × $622.18$451K
- 532 shares × $622.18$331K
- Pettiti GianlucaPresident & COO · Aug 28, 2026Shares withheld for taxes1,035 shares · $644KAvg. price $622.18
Show 4 price lots
- 304 shares × $622.18$189K
- 270 shares × $622.18$168K
- 249 shares × $622.18$155K
- 212 shares × $622.18$132K
- Shafer Michael DExecutive Vice President · Aug 28, 2026Shares withheld for taxes790 shares · $492KAvg. price $622.18
Show 4 price lots
- 227 shares × $622.18$141K
- 211 shares × $622.18$131K
- 190 shares × $622.18$118K
- 162 shares × $622.18$101K
- Britt Lisa P.Sr. VP and Chief HR Officer · Aug 28, 2026Shares withheld for taxes394 shares · $245KAvg. price $622.18
Show 4 price lots
- 116 shares × $622.18$72K
- 105 shares × $622.18$66K
- 87 shares × $622.18$54K
- 85 shares × $622.18$53K
- Meyer JamesSr. Vice President & CFO · Aug 28, 2026Shares withheld for taxes270 shares · $168KAvg. price $622.18
Show 5 price lots
- 114 shares × $622.18$71K
- 55 shares × $622.18$34K
- 44 shares × $622.18$28K
- 37 shares × $622.18$23K
- 20 shares × $622.18$12K
- Shropshire Thomas B Jr.SVP and General Counsel · Aug 28, 2026Shares withheld for taxes49 shares · $31KAvg. price $622.186,009 shares held after
- Holmes Joseph R.VP & Chief Accounting Officer · Aug 28, 2026Shares withheld for taxes50 shares · $31KAvg. price $622.1798
Show 4 price lots
- 15 shares × $622.18$9K
- 13 shares × $622.18$8K
- 11 shares × $622.18$7K
- 11 shares × $622.18$7K
- CASPER MARC NChairman & CEO · Aug 24, 2026Open-market sale275 shares · $172KAvg. price $627.0493
Show 4 price lots
- 101 shares × $625.41$63K
- 79 shares × $628.01$50K
- 62 shares × $628.74$39K
- 33 shares × $626.59$21K
- CASPER MARC NChairman & CEO · Aug 24, 2026Option exercise275 shares · $85KAvg. price $309.63124,200 shares held after
- Meyer JamesSr. Vice President & CFO · Aug 22, 2026Shares withheld for taxes31 shares · $19KAvg. price $629.275,830 shares held after
- CASPER MARC NChairman & CEO · Aug 21, 2026Open-market sale10,000 shares · $6.3MAvg. price $626.9153
Show 5 price lots
- 3,014 shares × $626.51$1.9M
- 2,727 shares × $625.46$1.7M
- 2,147 shares × $628.61$1.3M
- 1,791 shares × $627.39$1.1M
- 321 shares × $629.1$202K
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said Michael D. Shafer, its Executive Vice President, will retire effective December 31, 2026, announced on October 27, 2026.Published Oct 30, 2026 · Filed Oct 30, 2026Read the summary →
- AI summary8-KThe company said revenue for Q3 2026 rose 9% to $12.14 billion from $11.12 billion a year earlier, and organic revenue growth was 6%.Published Oct 21, 2026 · Filed Oct 21, 2026Read the summary →
- AI summary8-KThe company said it completed its acquisition of Clario Holdings, Inc., a provider of endpoint data solutions for clinical trials, on March 24, 2026. The purchase price is $8.875 billion in cash, and additional earnout and other payments that depend heavily on performance may also be made.Published Oct 2, 2026 · Filed Mar 24, 2026Read the summary →
- The company said Michael D. Shafer, its Executive Vice President, will retire effective December 31, 2026, announced on October 27, 2026.Read the full analysis →
- The company said revenue for Q3 2026 rose 9% to $12.14 billion from $11.12 billion a year earlier, and organic revenue growth was 6%.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Thermo Fisher Scientific (TMO) stock information
NYSE
Thermo Fisher Scientific (TMO) is listed on NYSE. Its market capitalization is about $259.8B. On trailing-twelve-month earnings the P/E ratio is 36.73, and the P/B ratio is 4.74. Return on equity is 12.9%. These figures are computed in-house from official filings and are reference information only.
Thermo Fisher Scientific — frequently asked questions
- What is the P/E ratio of Thermo Fisher Scientific (TMO)?
- On a trailing-twelve-month basis, TMO trades at a P/E ratio of 36.73. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Thermo Fisher Scientific?
- TMO has a market capitalization of about $259.8B. The figure moves with the share price and is refreshed each trading day.
- Does Thermo Fisher Scientific pay a dividend?
- TMO has a dividend yield of about 0.25%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.